You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Emergence of New ALK Mutations at Relapse of Neuroblastoma
|
|---|---|
| Published in |
Journal of Clinical Oncology, July 2014
|
| DOI | 10.1200/jco.2013.54.0674 |
| Pubmed ID | |
| Authors |
Gudrun Schleiermacher, Niloufar Javanmardi, Virginie Bernard, Quentin Leroy, Julie Cappo, Thomas Rio Frio, Gaelle Pierron, Eve Lapouble, Valérie Combaret, Frank Speleman, Bram de Wilde, Anna Djos, Ingrid Ora, Fredrik Hedborg, Catarina Träger, Britt-Marie Holmqvist, Jonas Abrahamsson, Michel Peuchmaur, Jean Michon, Isabelle Janoueix-Lerosey, Per Kogner, Olivier Delattre, Tommy Martinsson |
| Abstract |
In neuroblastoma, the ALK receptor tyrosine kinase is activated by point mutations. We investigated the potential role of ALK mutations in neuroblastoma clonal evolution. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 50% |
| United States | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Science communicators (journalists, bloggers, editors) | 1 | 50% |
| Practitioners (doctors, other healthcare professionals) | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 118 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Czechia | 1 | <1% |
| Unknown | 117 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 24 | 20% |
| Student > Ph. D. Student | 17 | 14% |
| Student > Master | 15 | 13% |
| Other | 9 | 8% |
| Student > Bachelor | 9 | 8% |
| Other | 21 | 18% |
| Unknown | 23 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 35 | 30% |
| Biochemistry, Genetics and Molecular Biology | 28 | 24% |
| Agricultural and Biological Sciences | 16 | 14% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
| Engineering | 2 | 2% |
| Other | 6 | 5% |
| Unknown | 28 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 August 2014.
All research outputs
#1,568,795
of 25,374,647 outputs
Outputs from Journal of Clinical Oncology
#3,862
of 22,046 outputs
Outputs of similar age
#15,365
of 239,927 outputs
Outputs of similar age from Journal of Clinical Oncology
#44
of 231 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,046 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.0. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 239,927 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 231 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.